Skip to content

Antiwei granule, a traditional Chinese medicine, in treatment of influenza: a prospective, multiple center, randomized, double-blind, placebo-controlled study

Antiwei granule, a traditional Chinese medicine, in treatment of influenza: a prospective, multiple center, randomized, double-blind, placebo-controlled study

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-09000390
Enrollment
Unknown
Registered
2009-05-07
Start date
2007-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

influenza-like disease and influenza

Interventions

Placebo group:placebo granule 6g Bid for 3 days
Antiwei group:Antiwei granule 6g Bid for 3 days

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Eligible patients were aged 18-65 years and presented within 36 h of onset of influenza-like illness with fever of at least 37.4 degree C with at least one respiratory symptoms (cough, sore throat, or nasal symptom) and at least one constitutional symptom (headache, malaise, myalgia, sweats or chills, or fatigue). All patients had to provide written informed consent. We excluded women who were pregnant, likely to become pregnant during the 28 days of the study, or who were breastfeeding.

Exclusion criteria

Exclusion criteria: suspected bacterial infection (based on symptoms, leukocyte count >10.0*10^9/L or neutrophil granulocyte level >=80%), resent use of influenza antiviral therapy, a history of drug or alcohol abuse, active clinically importa

Design outcomes

Primary

MeasureTime frame
amount of recovered patients;severity of illnes;

Secondary

MeasureTime frame
the rate of influenza virus positive conversion to negative;the severity of each symptom;the length of time to alleviation of fever within the first 24 hours;

Countries

China

Contacts

Public ContactWang Gang
wanglei@medmail.com.cn+86 028 81895617

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026